CD96 and neoplasm: Other preclinical studies have shown that blocking CD96 in combination with anti-PD1 or anti-CTLA-4 enhanced NK cell infiltration and IFN-γ production, thereby reducing tumor metastases in the lungs for various types of solid tumors [226].